Central Retinal Artery Occlusion (CRAO) marks a critical juncture in ophthalmology, characterized by the sudden cessation of blood flow in the central retinal artery, precipitating acute and painless vision loss in one eye. Typically arising from embolic obstruction, often originating from the carotid artery or heart, this condition mandates urgent intervention. While the macular region may display a distinctive cherry-red spot due to maintained choroidal circulation, the loss of vision is profound. Treatment strategies predominantly revolve around dislodging the embolus and reinstating blood flow, albeit with limited options and variable outcomes. Hypertension, diabetes, and cardiovascular disease serve as prominent risk factors, emphasizing the importance of vigilant monitoring and comprehensive management to avert recurrent episodes and mitigate associated complications.
Central retinal artery occlusion (CRAO) is an ophthalmic emergency that typically presents as a sudden, profound, and painless monocular visual loss, potentially leading to permanent blindness. While…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Central Retinal Artery Occlusion work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Central Retinal Artery Occlusion research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Central Retinal Artery Occlusion track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Central Retinal Artery Occlusion. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Central Retinal Artery Occlusion are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Central Retinal Artery Occlusion track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
